Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: The control group will be received Risperidone 6 mg per day and placebo (n = 30). Intervention 2: The case group will be treated with oral Risperidone 6 mg per day and 5-20 mg Memantin
Treatment - Drugs
The control group will be received Risperidone 6 mg per day and placebo (n = 30).
The case group will be treated with oral Risperidone 6 mg per day and 5-20 mg Memantine (n=30)
Sponsors
Clinical psychiatry research center, Tabriz university of medical sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Exclusion criteria: Substance abuse; IQ of less than 70; Medical history of other mental disorder; Other clinical and neurological disorders; Taking antipsychotic medications during last week or long acting antipsychotic medications during past month; Receiving ECT in the past two weeks; Sensitivity to Memantine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Schizophrenia severity. Timepoint: 6 monthes. Method of measurement: Clinical assesment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Two month after begining of the study. Method of measurement: Clinical assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Ashkan Yousefi
Tabriz university of medical sciences
Outcome results
None listed